This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Robert S. Gaston, MD; Arnold G. Diethelm, MD
University of Alabama at Birmingham School of Medicine

Ian Ayres, JD, PhD
Stanford Law School Palo Alto, Calif

Laura G. Dooley, JD
Valparaiso University School of Law Valparaiso, Ind

JAMA. 1994;271(4):270-271.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—We appreciate the comments of Ms Hassol, whose letter further emphasizes the impact of current UNOS allocation policies on equity. Many of the issues she raises are addressed by us in another article.¹ We are also pleased to note that Dr Wolicki found our article disturbing, for such was our intention. A technological triumph has indeed occurred in transplantation. Scientific and clinical advances have created unprecedented success and a growing demand for transplantable organs. Unfortunately, we see no indication that supply will grow sufficiently to meet this demand in the foreseeable future. Thus, allocation will remain critical. In the absence of compelling scientific evidence to the contrary, we believe equity in access to transplantation to be of utmost importance. Ours is not an attempt to inject race into an otherwise scientific debate: race is already recognized as a key facet of the overall question of equity in . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?